ES-SCLC

Clinical trials for ES-SCLC explained in plain language.

Never miss a new study

Get alerted when new ES-SCLC trials appear

Sign up with your email to follow new studies for ES-SCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug cocktail shows promise for tough lung cancer

Disease control Not yet recruiting

This study tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) to standard chemotherapy and chest radiation can help people with extensive-stage small cell lung cancer live longer without their cancer growing. About 46 adults who have not had prior treatme…

Matched conditions: ES-SCLC

Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Dalian Medical University • Aim: Disease control

Last updated May 15, 2026 12:04 UTC

ES-SCLC

Get alerted when new ES-SCLC trials appear

New drug cocktail shows promise for tough lung cancer